ANTICANCER COMPOSITION

The present invention relates to a composition comprising, as active ingredients: (1) a biguanide-based compound or a pharmaceutically acceptable salt thereof; (2) 2-deoxy-D-glucose; and (3) inositol hexaphosphate or a pharmaceutically acceptable salt thereof, inositol, or a mixture thereof. The com...

Full description

Saved in:
Bibliographic Details
Main Authors KIM EUN-JI, SUH MANUL, JUNG YI-EUN, JEONG JAE-IN
Format Patent
LanguageChinese
English
Published 17.08.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a composition comprising, as active ingredients: (1) a biguanide-based compound or a pharmaceutically acceptable salt thereof; (2) 2-deoxy-D-glucose; and (3) inositol hexaphosphate or a pharmaceutically acceptable salt thereof, inositol, or a mixture thereof. The composition according to the present invention exhibits a synergistic anticancer effect by appropriately combining specific drugs having a problem that needs to be used in a large amount, thereby making it possible to kill cancer cells in a small amount and effectively treat the cancer. Furthermore, the composition of the present invention may kill only cancer cells without side effects by exhibiting a specific toxic effect on cancer cells without showing toxicity on normal cells and thus may be usefully used as an anticancer agent and for preventing or improving cancer. 本发明涉及一种组合物，其包含作为活性成分的：(1)双胍基化合物或其药学上可接受的盐、(2)2-脱氧-D-葡萄糖和(3)肌醇六磷酸或其药学上可接受的盐、肌醇或它们的混合物。根据本发明的组合物通过适当地组合有需要大量使用问题的特定药物而表现出协同抗癌作用，从而使其能够在少量使用的情况下，杀死癌细胞并有
Bibliography:Application Number: CN201980085555